期刊文献+

血卟啉病的研究进展 被引量:3

Research progress of hematoporphyria
原文传递
导出
摘要 血卟啉病(Porphyrias)是因血红素合成路径中有关酶的缺乏导致卟啉类化合物代谢紊乱而发生的疾病,临床上主要表现是腹痛、神经精神症状及光感性皮肤损害,血卟啉病是一种罕见病,有资料统计欧洲国家每年歇性卟啉病(AIP)新发病例比例约为0.13/百万人^([1]),本综述将阐述临床上常见的卟啉病如AIP、迟发皮肤性卟啉病(PCI)、红细胞生成性卟啉病等的发病机制、临床表现、诊断、治疗及预后等相关研究进展。 Hematoporphyrias are a group of metabolic disorders of the haem biosynthesis pathway that the abnormal function of several separate enzymatic steps lead to specific accumulation of haem precursors.The typical clinical symptoms present acute neurovisceral symptoms,photosensitivity skin lesions and abdominal symptoms.Hematoporphyrias are still underdiagnosed and if clinical presentation especially dark red or black urine are suspected,specific treatments should be applied as soon as possible.In this review,we describe pathogenesis,salient clinical performance and main measures of the most common clinical types of hematoporphyrias.
出处 《临床血液学杂志(输血与检验)》 CAS 2015年第6期1103-1106,共4页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 血卟啉病 卟啉类化合物 5-氨基乙酰丙酸 卟胆原 血红素 hematoporphyria porphyrin 5-Aminolevulinicacid porphobilinogen hemoglobi
  • 相关文献

参考文献33

  • 1Elder G, Harper P, Badminton M, et al. The inci- dence of inherited porphyrias in Europe[J]. J Inherit Metab Dis, 2013, 36:849-857.
  • 2Thunell S. (Far) Outside the box.. genomic approach to acute porphyria[J]. Physiol Res , 2006, 55 : $43- $66.
  • 3Delaby C, To-Figueras J, Deybach JC, et al. Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients [J].J Intern Med ,2009, 266.. 277-285.
  • 4Bloomer JR, Bonkovsky HL. Theporphyrias[J]. Dis Mon,1989,35:1-54.
  • 5Casals G, Marcos J, Pozo OJ, et al. Gas chromatogra- phy-mass spectrometry profiling of steroids in urine of patients with acute intermittent porphyria [J]. Clin Biochem, 2013,46 .. 819 - 824.
  • 6Larion S, Caballes FR, Hwang SI, et al. Circadian rhythms in acute intermittent porphyria-a pilot study [J]. EurJ ClinInvest,2013,43:727-739.
  • 7Pozo OJ, Marcos J, Fabregat A, et al. Adrenal hormo- nal imbalance in acuteintermittent porphyria patients.. results of a case control study[J]. Orphanet J Rare Dis,2014,9:54.
  • 8Andersson C, Wikberg A, Stegmayr B, et al. Renal symptomatology in patients with acute intermittent porphyria. A populationbased study[J]. J Intern Med, 2000,248:319-325.
  • 9Sardh E, Andersson DE, Henrichson A, et al. Por- phyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal Jisease under different therapyregimes[J]. Cell MolBiol (Noisy-le-grand), 2009,55..66-71.
  • 10Bonkovsky HL, Guo JT, Hou W, et al. Porphyrin and heme metabolism and the porphyrias[J]. Compr Physiol, 2013, 3 .. 365- 401.

同被引文献11

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部